Search Within

Connie Wing-Ching Lee Batlevi

Formats
  1. Meeting Abstract (109)
  2. Journal Article (52)
  3. Research Letter (5)
  4. Book Section (4)
  5. Miscellaneous (2)
  6. Review (2)
  7. Correspondence (1)
  8. Editorial (1)
Groups
  1. Center for Hematologic Malignancies (176)
  2. Department of Medicine (176)
  3. Hematologic Malignancies, Division of (176)
  4. Lymphoma (176)
  5. Survivorship Research (117)
  6. Epidemiology and Biostatistics (89)

More Groups

People
  1. Maria Palomba (98)
  2. Anas Younes (81)
  3. Andrew Zelenetz (76)
  4. Matthew Matasar (70)
  5. David Straus (61)
  6. Ariela Noy (60)

More People

Years
  1. 2024 (2)
  2. 2023 (11)
  3. 2022 (30)
  4. 2021 (27)
  5. 2020 (27)
  6. 2019 (34)

More Years

Publications
  1. Blood (69)
  2. Hematological Oncology (16)
  3. Blood Advances (12)
  4. Journal of Clinical Oncology (10)
  5. Blood Cancer Journal (6)
  6. Biology of Blood and Marrow Transplantation (5)

More Publications

Publishers
  1. American Society of Hematology (82)
  2. Wiley Blackwell (16)
  3. Elsevier Inc. (15)
  4. Nature Publishing Group (15)
  5. American Society of Clinical Oncology (10)
  6. John Wiley & Sons (4)

More Publishers

Results (176)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • DLBCL patients treated with CD19 CAR T cells experience a high burden of organ toxicities but low nonrelapse mortality
    Journal Article

    Wudhikarn, K.; Pennisi, M.; Garcia-Recio, M.; Flynn, J. R.; Afuye, A.; Silverberg, M. L.; Maloy, M. A.; Devlin, S. M.; Batlevi, C. L.; Shah, G. L.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Baseline FDG-PET/CT detects bone marrow involvement in follicular lymphoma and provides relevant prognostic information
    Journal Article

    Nakajima, R.; Moskowitz, A. J.; Michaud, L.; Mauguen, A.; Batlevi, C. L.; Dogan, A.; Schöder, H.
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Infectious complications in aggressive B cell non-Hodgkin lymphoma after CD-19 chimeric antigen receptor T cell therapy
    Meeting Abstract

    Wudhikarn, K.; Pennisi, M.; Garcia Recio, M.; Maloy, M. A.; Shah, G. L.; Scordo, M.; Dahi, P. B.; Sauter, C. S.; Batlevi, C. W.; Palomba, M. L.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Burden and impact of toxicities on outcomes for aggressive B cell non-Hodgkin lymphoma patients after CD19-directed chimeric antigen receptor T cell: Real-world experience
    Meeting Abstract

    Wudhikarn, K.; Pennisi, M.; Garcia Recio, M.; Flynn, J.; Maloy, M. A.; Devlin, S. M.; Batlevi, C. W.; Shah, G. L.; Scordo, M.; Palomba, M. L.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Comparing car T cells toxicities grading systems: Application of ASTCT grading system and implications for management
    Meeting Abstract

    Pennisi, M.; Jain, T.; Mead, E.; Santomasso, B.; Silverberg, M. L.; Batlevi, Y.; Shouval, R.; Devlin, S. M.; Batlevi, C. W.; Brentjens, R.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Comparing CAR T-cell toxicity grading systems: Application of the ASTCT grading system and implications for management
    Journal Article

    Pennisi, M.; Jain, T.; Santomasso, B. D.; Mead, E.; Wudhikarn, K.; Silverberg, M. L.; Batlevi, Y.; Shouval, R.; Devlin, S. M.; Batlevi, C.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Positron-emission tomography–based staging reduces the prognostic impact of early disease progression in patients with follicular lymphoma
    Journal Article

    Batlevi, C. L.; Sha, F.; Alperovich, A.; Ni, A.; Smith, K.; Ying, Z.; Gerecitano, J. F.; Hamlin, P. A.; Horwitz, S. M.; Joffe, E.; more...
    European Journal of Cancer (2020)

    Fulltext@MSK | Save
  • A multi-center dose-finding study to assess safety, tolerability, pharmacokinetics and preliminary efficacy of fimepinostat (CUDC-907) in combination with venetoclax in patients with relapsed/refractory (R/R) lymphoma
    Meeting Abstract

    Younes, A.; Batlevi, C. L.; Cohen, J. B.; de Vos, S.; Landsburg, D. J.; Myint, Z. W.; Patel, K.; Phillips, T. J.; Smith, S. M.; Westin, J. R.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Retrospective analysis of gemcitabine and oxaliplatin (GemOx)-based treatment in patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma
    Meeting Abstract

    Schade, J. R.; Kim, C.; Drill, E.; Qiu, A.; Batlevi, C. L.; Caron, P.; Colbourn, D. S.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Comparing gradings of immune effector cells toxicities: Application of ASTCT consensus grading system and implications for clinical management
    Meeting Abstract

    Pennisi, M.; Jain, T.; Mead, E.; Santomasso, B.; Silverberg, M. L.; Batlevi, Y.; Shouval, R.; Maloy, M. A.; Devlin, S. M.; Batlevi, C. L.; more...
    Blood (2019)

    Fulltext@MSK | Save